Earnings To Watch: U.S. Physical Therapy (USPH) Reports Q2 Results Tomorrow
U.S. Physical Therapy (NYSE: USPH) will report Q2 earnings Wednesday after the bell. The company previously reported $198.3M revenue, up 7.9% YoY, but missed EPS estimates. For the upcoming quarter, analysts expect revenue up 6.4% YoY. The article cites an average analyst price target of $93.67 versus $77.88 and notes peer results from Centene and Tenet.
How this was made
The 30-second read
Why it matters
The key trading question is whether the EPS miss reflects temporary noise or a structural margin issue, especially with consensus revenue growth expected to slow to 6.4% YoY.
Market read
Provides a checklist for the upcoming print, highlighting slower revenue growth expectations and a prior EPS miss that can drive after-hours repricing.
What to watch
The article does not provide guidance details, margin drivers, or cost trends; traders should focus on management commentary for what caused the EPS miss and whether it affects forward profitability.
Background
The article is an earnings preview for U.S. Physical Therapy ahead of its Q2 report after the bell, referencing last quarter’s revenue beat and EPS miss plus consensus expectations.
Ticker impact
US Physical Therapy reports Q2 earnings after the bell, with the article citing revenue of $198.3M and an EPS miss versus estimates.
Near-term volatility likely around after-hours results, with direction dependent on whether EPS weakness was transitory and whether revenue/guidance re-accelerate.
The text provides concrete prior-quarter revenue and notes a significant EPS miss, plus consensus revenue growth slowing to 6.4% YoY, which typically drives post-earnings repricing if margins or outlook disappoint further.
Market effects
Healthcare providers and services are referenced via peer results, implying read-across risk for outpatient therapy demand and reimbursement sentiment.
No explicit regional impact beyond U.S. equities.
Limited, as the article is U.S.-company earnings-focused with no global macro linkage.
Counterpoint
Despite the EPS miss, the company “rarely misses” revenue estimates, so the stock could hold up if revenue quality remains intact and the EPS miss is explained by non-recurring items.
Key entities
- companyU.S. Physical Therapy
Outpatient physical therapy provider scheduled to report Q2 results after the bell.
- peerCentene
Peer cited as having beaten Q2 revenue expectations and traded down after results.
- peerTenet Healthcare
Peer cited as having topped Q2 revenue estimates and traded up after results.
